Azacitidine | Interleukin Related interleukin-related.com

Product Name :
Azacitidine

Search keywords :
Cytosine

drugId :
null

Target Vo:
DNA (cytosine-5)-methyltransferase 1

Target Vo Short Name :
DNMT1

Moa_Name:
DNA (cytosine-5)-methyltransferase 1 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2004

Origin Company_Name :
Celgene Corp

Active Company_Name :
Aprea Therapeutics Ab

Active Indication_Name:
Leukemia, Myelomonocytic, Juvenile

In Active Indication_Name:
beta-Thalassemia

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ku70 Antibody (YA319)
Anti-Aurora A Antibody
Phospho-RSK4 (Ser232) Antibody: Phospho-RSK4 (Ser232) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Phospho-RSK4 (Ser232). It can be used for WB,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts